Sign Up to like & get
recommendations!
1
Published in 2021 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-021-00823-6
Abstract: Despite its history as one of the most impactful toxicities associated with cytotoxic cancer therapy, oral mucositis (OM) remains an unmet clinical need which affects hundreds of thousands of patients. Descriptions of its complex pathogenesis…
read more here.
Keywords:
current options;
mucositis;
treatment oral;
oral mucositis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2021.1951701
Abstract: ABSTRACT Introduction: Accumulating evidence supports a bidirectional association between nonalcoholic steatohepatitis (NASH) and type 2 diabetes (T2D). There is a clinical challenge to consider pharmaceutical strategies targeting the metabolic dysfunction common to NASH and T2D…
read more here.
Keywords:
current options;
diabetic drugs;
anti diabetic;
nash current ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2033207
Abstract: ABSTRACT Introduction Current treatments of eosinophilic esophagitis (EoE) induce symptomatic and histological remission in a proportion of patients. However, they do not fully meet patients’ needs and limitations should be acknowledged. The growing epidemiology of…
read more here.
Keywords:
investigational drugs;
eosinophilic esophagitis;
current options;
drugs treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2019.1705784
Abstract: ABSTRACT Introduction: The epidemiology of eosinophilic esophagitis (EoE) has increased rapidly to represent a common cause of chronic and recurrent esophageal symptoms. Current treatment options have limitations so the development of novel therapies is a…
read more here.
Keywords:
current options;
esophagitis current;
pharmacological treatments;
treatments eosinophilic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2017.1339596
Abstract: ABSTRACT Introduction: Waldenström’s macroglobulinemia (WM) is a rare, incurable B-cell lymphoma, with a median survival of 5–10 years in symptomatic patients. There is no consensus on the standard of care and several agents are currently…
read more here.
Keywords:
current options;
waldenstr macroglobulinemia;
manage waldenstr;
macroglobulinemia ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "JBJS Reviews"
DOI: 10.2106/jbjs.rvw.18.00044
Abstract: For posterosuperior tears, even though these are not absolute contraindications, the following preoperative variables have been found to significantly correlate with poorer outcomes when performing a latissimus dorsi tendon transfer (or possibly even other tendon…
read more here.
Keywords:
current options;
cuff tears;
rotator cuff;
tendon transfers ... See more keywords